Lacosamide

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

70 API Suppliers, 31 USDMF, 23 CEP/COS, 6 JDMF, 23 EU WC, 11 KDMF, 21 NDC API, 43 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

9 Drugs in Development

9 Drugs in Development

INTERMEDIATES

11 Intermediates Suppliers

11 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

492 FDF Dossiers, 103 FDA Orange Book, 176 Europe, 46 Canada, 125 Australia, 4 South Africa, 38 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 100MG, TABLET;ORAL - 150MG, TABLET;ORAL - 200MG, TABLET;ORAL - 50MG

RELATED EXCIPIENT COMPANIES

4 Rochem International Inc, 3 SPI Pharma, 2 Seqens, 5 DKSH, 1 Faran Shimi Pharmaceutical, 8 Gangwal Healthcare, 3 Nanjing Well Pharmaceutical, 1 ACG Worldwide, 8 Actylis, 1 Aeon Procare, 5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 10 BASF, 10 Corel Pharma Chem, 2 DFE Pharma, 2 Finar, 7 Gangwal Chemicals, 7 Ideal Cures Pvt Ltd, 17 Kerry, 4 Kima Chemical, 6 Lonza Capsugel, 11 Microlex e.U, 2 Nomisma Healthcare, 2 Novo Excipients, 1 Pharmatrans-Sanaq, 2 Pluviaendo, 2 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 18 Roquette, 6 Seppic, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 9 Sigachi Industries, 3 The Dow Chemical Company, 1 Valens Pharmachem, 2 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

53 Coating Systems & Additives, 30 Fillers, Diluents & Binders, 28 Controlled & Modified Release, 22 Thickeners and Stabilizers, 18 Film Formers & Plasticizers, 15 Direct Compression, 13 Parenteral, 13 Lubricants & Glidants, 12 Topical, 11 Taste Masking, 11 Solubilizers, 9 Co-Processed Excipients, 9 Disintegrants & Superdisintegrants, 8 Granulation, 6 Emulsifying Agents, 6 Chewable & Orodispersible Aids, 5 Coloring Agents, 5 Rheology Modifiers, 5 Empty Capsules, 5 API Stability Enhancers, 4 Vegetarian Capsules, 1 Soft Gelatin

DIGITAL CONTENT

2 DATA COMPILATION #PharmaFlow, 75 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

168 Finished Drug Prices, 11 Annual Reports

MARKET PLACE

19 APIs, 6 FDF Dossiers

PATENTS & EXCLUSIVITIES

18 US Patents, 12 US Exclusivities, 10 Health Canada Patents

REF. STANDARDS & IMPURITIES

7 Others

7 Others

$ Xls

Filters

Xls

USFDA APPLICATION NUMBER - 22253 / DOSAGE - TABLET;ORAL - 100MG

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
LACOSAMIDE(UNII: 563KS2PQY5) (LACOSAMIDE - UNII:563KS2PQY5)	LACOSAMIDE	100mg

Inactive Ingredients

Ingredient Name	Alembic Pharmaceuticals Inc.	Florida Pharmaceutical Products, LLC	Indoco Remedies Limited	Natco Pharma Limited	NorthStar RxLLC	Tris Pharma Inc	Glenmark Pharmaceuticals Inc. USA	REMEDYREPACK INC.	Ascend Laboratories, LLC
CELLULOSE, MICROCRYSTALLINE(OP1R32D61U)
CROSPOVIDONE (120 .MU.M)(68401960MK)
CROSPOVIDONE (15 MPA.S AT 5%)(68401960MK)
CROSPOVIDONE(2S7830E561)
CROSPOVIDONE(68401960MK)
FD&C BLUE NO. 2(L06K8R7DQK)
FERRIC OXIDE RED(1K09F3G675)
FERRIC OXIDE YELLOW(EX438O2MRT)
FERROSOFERRIC OXIDE(XM0M87F357)
HYDROXYPROPYL CELLULOSE (110000 WAMW)(5Y0974F5PW)
HYDROXYPROPYL CELLULOSE (1600000 WAMW)(RFW2ET671P)
HYDROXYPROPYL CELLULOSE (90000 WAMW)(UKE75GEA7F)
HYDROXYPROPYL CELLULOSE(RFW2ET671P)
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED(2165RE0K14)
HYDROXYPROPYL CELLULOSE, UNSPECIFIED(9XZ8H6N6OH)
HYPROMELLOSE, UNSPECIFIED(3NXW29V3WO)
HYPROMELLOSES(3NXW29V3WO)
ISOPROPYL ALCOHOL(ND2M416302)
LECITHIN, SOYBEAN(1DI56QDM62)
LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE, UNSPECIFIED(2165RE0K14)
MAGNESIUM STEARATE(70097M6I30)
MICROCRYSTALLINE CELLULOSE(OP1R32D61U)
POLYETHYLENE GLYCOL 3350(G2M7P15E5P)
POLYETHYLENE GLYCOL 400(B697894SGQ)
POLYETHYLENE GLYCOL 6000(30IQX730WE)
POLYETHYLENE GLYCOL(3WJQ0SDW1A)
POLYETHYLENE GLYCOL, UNSPECIFIED(3WJQ0SDW1A)
POLYETHYLENE GLYCOLS(3WJQ0SDW1A)
POLYVINYL ALCOHOL(532B59J990)
POLYVINYL ALCOHOL, UNSPECIFIED(532B59J990)
SILICON DIOXIDE(ETJ7Z6XBU4)
TALC(7SEV7J4R1U)
TITANIUM DIOXIDE(15FIX9V2JP)

Drug Product Composition: Lacosamide

Lacosamide

Lacosamide

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

70 API Suppliers

31 USDMF

23 CEP/COS

6 JDMF

23 EU WC

11 KDMF

21 NDC API

43 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

9 Drugs in Development

INTERMEDIATES

11 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

492 FDF Dossiers

103 FDA Orange Book

176 Europe

46 Canada

125 Australia

4 South Africa

38 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 100MG

TABLET;ORAL - 150MG

TABLET;ORAL - 200MG

TABLET;ORAL - 50MG

RELATED EXCIPIENT COMPANIES

4 Rochem International Inc

3 SPI Pharma

2 Seqens

5 DKSH

1 Faran Shimi Pharmaceutical

8 Gangwal Healthcare

3 Nanjing Well Pharmaceutical

1 ACG Worldwide

8 Actylis

1 Aeon Procare

5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

10 BASF

10 Corel Pharma Chem

2 DFE Pharma

2 Finar

7 Gangwal Chemicals

7 Ideal Cures Pvt Ltd

17 Kerry

4 Kima Chemical

6 Lonza Capsugel

11 Microlex e.U

2 Nomisma Healthcare

2 Novo Excipients

1 Pharmatrans-Sanaq

2 Pluviaendo

2 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

1 Qualicaps

18 Roquette

6 Seppic

3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Shijiazhuang Huaxu Pharmaceutical

9 Sigachi Industries

3 The Dow Chemical Company

1 Valens Pharmachem

2 Vasa Pharmachem

1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

53 Coating Systems & Additives

30 Fillers, Diluents & Binders

28 Controlled & Modified Release

22 Thickeners and Stabilizers

18 Film Formers & Plasticizers

15 Direct Compression

13 Parenteral